United States EGFR Mutation Test Market was valued at USD 1.00 Billion in 2022 and is projected to reach USD 1.75 Billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030.
The US EGFR Mutation Test Market is experiencing significant growth due to its pivotal role in detecting specific genetic mutations, especially for patients with non-small cell lung cancer (NSCLC). The market is expected to expand as industries continue to demand more accurate, reliable, and accessible diagnostic solutions. This is largely driven by the rise in cancer diagnoses and the increasing use of personalized medicine. EGFR (epidermal growth factor receptor) mutations play a crucial role in the development and progression of certain cancers, making EGFR mutation testing essential for targeted therapy. In recent years, there has been an increased focus on developing advanced testing methods, including liquid biopsy and next-generation sequencing (NGS), which provide more accurate results and less invasive options for patients.
The US EGFR Mutation Test Market is characterized by various types of testing methods. PCR (Polymerase Chain Reaction) testing is one of the traditional and widely used methods. It has proven effective in detecting EGFR mutations, especially in tissue samples. However, as technology advances, NGS is becoming the go-to method due to its high sensitivity and ability to analyze multiple mutations at once. Liquid biopsy, another emerging technique, allows for non-invasive sample collection through blood, providing a simpler and quicker alternative for both patients and healthcare professionals. This versatility in testing methods caters to the diverse requirements of the medical community, especially in oncology clinics and research laboratories.
The increasing need for EGFR mutation testing is largely influenced by the rising prevalence of NSCLC cases in the US. The demand from pharmaceutical companies for accurate biomarkers to guide the development of targeted therapies is also a significant factor. Moreover, as awareness of personalized medicine grows, hospitals, research institutions, and diagnostic labs are increasingly adopting these tests to ensure better patient outcomes and treatment efficacy. The ability to tailor treatment plans based on the mutation status of a patient has proven to significantly improve survival rates and quality of life, thus further driving the EGFR Mutation Test Market's growth.
Additionally, the integration of EGFR mutation testing into routine clinical practice is becoming more common. It helps in identifying patients who are likely to benefit from EGFR inhibitors, such as Erlotinib and Gefitinib, which have been successful in treating NSCLC. As more healthcare providers recognize the benefits of early detection and targeted therapy, the demand for these tests is poised to increase, making EGFR mutation testing an indispensable tool in the fight against cancer.
Get an In-Depth Research Analysis of the US EGFR Mutation Test Market Size And Forecast [2025-2032]
Abbott
Merck
Thermo Fisher Scientific
Illumina
BioMerieux
QIAGEN
Agilent Technologies
Hologic
Novartis
Roche
Genomic Health
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US EGFR Mutation Test Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US EGFR Mutation Test Market
Biopsy-based tests
Blood-based tests
Urine-based tests
Cancer Diagnostics
Personalized Medicine
Drug Resistance Monitoring
Prognostic Biomarkers
Hospitals
Diagnostic Laboratories
Research Institutions
Oncology Clinics
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Fluorescence In Situ Hybridization (FISH)
Immunohistochemistry (IHC)
Reagents & Kits
Instruments
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ EGFR Mutation Test Market Research Analysis
1. Introduction of the US EGFR Mutation Test Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US EGFR Mutation Test Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US EGFR Mutation Test Market, By Type
6. US EGFR Mutation Test Market, By Application
7. US EGFR Mutation Test Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US EGFR Mutation Test Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/